Jeff Evanson Joins Navigant Life Sciences Practice as Managing Director
March 25 2015 - 8:30AM
Business Wire
Industry executive supports product development and
commercialization within the pharmaceutical and medical technology
sectors
Today, Navigant (NYSE: NCI) announced that Jeff Evanson has
joined the Life Sciences practice as Managing Director. In his
role, Evanson will assist Life Sciences clients’ growth plans
through product and portfolio strategy, global launches and market
development.
Evanson joins Navigant from Novartis (Alcon) where he was the
Vice President and Global Commercial Head of the Pharmaceutical
Franchise, a $4.2 billion division of Novartis (Alcon). During his
four and a half year tenure there, he was responsible for aspects
of strategy, portfolio, global brands, launches and campaigns
initially for retina, then more broadly for all of the
pharmaceutical products.
“Jeff is an innovative global business leader who brings a broad
range of experience leading projects and building teams to identify
growth opportunities in competitive environments and leveraging
existing technology to expand into new therapeutic areas,” said
Eduardo Schur, Managing Director and global leader of Navigant’s
Life Sciences practice.
Prior to Novartis, Jeff spent 10 years at Medtronic in a variety
of pre-commercialization and post-commercialization roles. He has
extensive experience leading creating Opportunity Assessment
through to Global Launch Plans and Life Cycle Management. These
responsibilities allowed Jeff direct experience with global
regulators and payers alike. Jeff also has experience in
Pharmaceutical Sales and Sales Training.
“The pharmaceutical and medical technology industries are
expanding at an incredible pace as innovation continues to fuel new
growth. I am excited to join the team of experts within Navigant’s
Life Sciences practice to strategize with our clients and help them
achieve continued growth and developmental goals,” said
Evanson.
Jeff received his MBA from the University of Minnesota and a BA
in Chemistry from the University of St. Thomas in St. Paul
Minnesota. He also has gained key insight and experience as a
two-term Board Member of Gillette Children’s Hospital in St. Paul,
Minnesota, from 2008 to 2014.
About Navigant
Navigant (NYSE: NCI) is a specialized, global professional
services firm dedicated to assisting clients in creating and
protecting value in the face of critical business risks and
opportunities. Through senior level engagement with clients,
Navigant professionals deliver expert and advisory work through
implementation and business process management services. The firm
combines deep technical expertise in Disputes and Investigations,
Economics, Financial Advisory and Management Consulting, with
business pragmatism to address clients’ needs in highly regulated
industries, including Construction, Energy, Financial Services and
Healthcare. More information about Navigant can be found at
navigant.com.
For more information contact:Navigant Healthcare
MarketingJennifer Fales312.583.2195
Navigant Consulting (NYSE:NCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Navigant Consulting (NYSE:NCI)
Historical Stock Chart
From Apr 2023 to Apr 2024